Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H de Wilt

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|March 29, 2000
Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusionJ H de Wilt, T L ten Hagen, G de Boeck, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Tumor necrosis factor-alpha augments tumor effects in isolated hepatic perfusion with melphalan in a rat sarcoma modelM G van Ijken, B van Etten, J H de Wilt, et al.
British Journal of Cancer|March 25, 2000
TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effectsA H van der Veen, J H de Wilt, A M Eggermont, et al.
Anticancer Research|December 29, 2000
Synergistic antitumour effect of TNF-SAM2 with melphalan and doxorubicin in isolated limb perfusion in ratsJ H de Wilt, G Soma, T L ten Hagen, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 28, 2001
Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisalT Terkivatan, J H de Wilt, R A de Man, et al.
International Journal of Cancer|May 21, 2014
Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factorNiek Hugen, Rob H Verhoeven, Valery E Lemmens, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
High-dose-rate intraoperative radiotherapy for close or positive margins in patients with locally advanced or recurrent rectal cancerJoost J Nuyttens, Inger-Karine K Kolkman-Deurloo, Maarten Vermaas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2016
Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resectionJannemarie A M de Ridder, Eric P van der Stok, Leonie J Mekenkamp, et al.
British Journal of Cancer|October 12, 2000
Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusionsJ H de Wilt, E R Manusama, B van Etten, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2016
Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in the NetherlandsJ 't Lam-Boer, E P van der Stok, J Huiskens, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|March 29, 2000
Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusionJ H de Wilt, T L ten Hagen, G de Boeck, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Tumor necrosis factor-alpha augments tumor effects in isolated hepatic perfusion with melphalan in a rat sarcoma modelM G van Ijken, B van Etten, J H de Wilt, et al.
British Journal of Cancer|March 25, 2000
TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effectsA H van der Veen, J H de Wilt, A M Eggermont, et al.
Anticancer Research|December 29, 2000
Synergistic antitumour effect of TNF-SAM2 with melphalan and doxorubicin in isolated limb perfusion in ratsJ H de Wilt, G Soma, T L ten Hagen, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 28, 2001
Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisalT Terkivatan, J H de Wilt, R A de Man, et al.
International Journal of Cancer|May 21, 2014
Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factorNiek Hugen, Rob H Verhoeven, Valery E Lemmens, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
High-dose-rate intraoperative radiotherapy for close or positive margins in patients with locally advanced or recurrent rectal cancerJoost J Nuyttens, Inger-Karine K Kolkman-Deurloo, Maarten Vermaas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2016
Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resectionJannemarie A M de Ridder, Eric P van der Stok, Leonie J Mekenkamp, et al.
British Journal of Cancer|October 12, 2000
Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusionsJ H de Wilt, E R Manusama, B van Etten, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2016
Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in the NetherlandsJ 't Lam-Boer, E P van der Stok, J Huiskens, et al.
Pageof 4